IMAC Inc. (IMAC)
NASDAQ: IMAC
· Real-Time Price · USD
1.01
0.02 (2.00%)
At close: Aug 08, 2022, 6:00 AM
IMAC Revenue Breakdown
Period Ending | Dec 31, 2020 |
---|---|
Patient Revenues Revenue | 12.82M |
Patient Revenues Revenue Growth | n/a |
Operating Expense Breakdown
Period Ending | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Selling, General, and Administrative Revenue | 2.1B | 2.19M | -7.16M | 5.46M | 5.1M | 4.35M | -2.83M | 3.93M | 3.84M | 4.49M | 4.66M | 4.62M | 4.54M | 3.39M | 3.5M | 2.97M | 1.41M | 783.41K | 570.07K | 414.93K |
Selling, General, and Administrative Revenue Growth | +95999.34% | -130.52% | -231.10% | +7.18% | +17.17% | -253.47% | -172.18% | +2.29% | -14.41% | -3.78% | +0.88% | +1.68% | +33.93% | -2.95% | +17.56% | +110.20% | +80.58% | +37.42% | +37.39% | n/a |
Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales and Marketing Revenue | 242.56M | 370.49K | 449.59K | 294.05K | 315.53K | 265.55K | 517.17K | 234.69K | 174.35K | 241.82K | 224.21K | 317.8K | 349.33K | 347.02K | 388.99K | 291.69K | 85.33K | 93.18K | 58.71K | 22.06K |
Sales and Marketing Revenue Growth | +65370.95% | -17.59% | +52.90% | -6.81% | +18.82% | -48.65% | +120.36% | +34.61% | -27.90% | +7.85% | -29.45% | -9.03% | +0.67% | -10.79% | +33.36% | +241.82% | -8.42% | +58.71% | +166.18% | n/a |